AUTOIMMUNE HEMOLYTIC ANEMIA
Clinical trials for AUTOIMMUNE HEMOLYTIC ANEMIA explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE HEMOLYTIC ANEMIA trials appear
Sign up with your email to follow new studies for AUTOIMMUNE HEMOLYTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cell therapy offers hope for tough anemia cases
Disease control Not yet recruitingThis early-stage trial tests a new cell therapy called YTS109 for people with a severe type of anemia where the body attacks its own red blood cells. It is for patients who have not gotten better after at least three other treatments. The study will check if the therapy is safe a…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA
Phase: PHASE1 • Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 04:18 UTC
-
New drug hope for patients with relapsed blood disorder
Disease control Not yet recruitingThis early-phase study tests a new drug, enatumab, in 3 adults with relapsed or refractory warm antibody autoimmune hemolytic anemia (wAIHA), a condition where the immune system attacks red blood cells. Current treatments often stop working or cause relapses. The goal is to see i…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA
Phase: PHASE2 • Sponsor: Bing Han • Aim: Disease control
Last updated May 26, 2026 04:16 UTC
-
New pill offers hope for rare blood disorder
Disease control Not yet recruitingThis study tests a daily pill called linprixel for people with autoimmune hemolytic anemia that hasn't improved with other treatments. The goal is to see if the drug can control the disease by improving blood counts. About 22 adults will take the pill for up to 12 weeks, with the…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA
Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated May 26, 2026 04:14 UTC
-
New CAR-T therapy takes on rare blood disorder
Disease control Not yet recruitingThis early-phase study tests a new treatment called IASO206 for people with a severe type of autoimmune hemolytic anemia that hasn't responded to standard therapies. The treatment uses a special type of cell therapy (in vivo CAR-T) to target and destroy faulty immune cells that a…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 26, 2026 03:56 UTC
-
New cell therapy offers hope for Hard-to-Treat anemia
Disease control Not yet recruitingThis early-stage study tests a new cell therapy called YTS109 for people with autoimmune hemolytic anemia that hasn't improved after at least three prior treatments. The therapy uses specially designed immune cells to target and destroy the faulty cells causing the anemia. The ma…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA
Phase: PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 20, 2026 11:56 UTC